Maternal adiposity as an independent risk factor for pre-eclampsia: A meta-analysis of prospective cohort studies

Obesity Reviews

Volumn 14, Issue 6, 2013, Pages 508-521

  Wang, Z ^a   Wang, P ^a   Liu, H ^b   He, X ^a   Zhang, J ^c   Yan, H ^d   Xu, D ^e   Wang, B ^a  

^a Maternal and Children Health's Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

^d The 210th Hospital of PLA   (China)

^e THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Obesity; Pre eclampsia

Indexed keywords

ARTICLE; BODY WEIGHT; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; META ANALYSIS; MULTIPARA; NULLIPARA; PREECLAMPSIA; PREGNANT WOMAN; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ADIPOSITY; COHORT STUDIES; FEMALE; HUMANS; PARITY; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84876864260     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12025     Document Type: Article

References (61)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631-644.
2. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074.
3. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-2869.
4. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56.
5. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003; 361: 1511-1517.
6. Broughton Pipkin F. Risk factors for preeclampsia. N Engl J Med 2001; 344: 925-926.
7. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-1209.
8. Berrington de Gonzalez A, Hartge P, Cerhan JR etal. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-2219.
9. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 2011; 25: 329-342.
10. Begum KS, Sachchithanantham K, De Somsubhra S. Maternal obesity and pregnancy outcome. Clin Exp Obstet Gynecol 2011; 38: 14-20.
11. Magnus P, Trogstad L, Owe KM, Olsen SF, Nystad W. Recreational physical activity and the risk of preeclampsia: a prospective cohort of Norwegian women. Am J Epidemiol 2008; 168: 952-957.
12. Ness RB, Zhang J, Bass D, Klebanoff MA. Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth. Am J Epidemiol 2008; 168: 427-433.
13. Fortner RT, Pekow P, Solomon CG, Markenson G, Chasan-Taber L. Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. Am J Obstet Gynecol 2009; 200: 167 e1-167 e7.
14. Sibai BM, Ewell M, Levine RJ etal. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177: 1003-1010.
15. Weiss JL, Malone FD, Emig D etal. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol 2004; 190: 1091-1097.
16. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475-482.
17. Anderson NH, McCowan LM, Fyfe EM etal. The impact of maternal body mass index on the phenotype of pre-eclampsia: a prospective cohort study. BJOG 2012; 119: 589-595.
18. Group HSCR. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 2010; 117: 575-584.
19. North RA, McCowan LM, Dekker GA etal. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342: d1875.
20. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007; 18: 234-239.
21. Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 2006; 17: 428-434.
22. Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007; 36: 412-419.
23. Dennedy MC, Avalos G, O'Reilly MW, O'Sullivan EP, Gaffney G, Dunne F. ATLANTIC-DIP: raised maternal body mass index (BMI) adversely affects maternal and fetal outcomes in glucose-tolerant women according to International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Clin Endocrinol Metab 2012; 97: E608-E612.
24. Gaillard R, Steegers EA, Hofman A, Jaddoe VW. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens 2011; 29: 937-944.
25. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103: 219-224.
26. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol 1998; 92: 174-178.
27. Rode L, Nilas L, Wojdemann K, Tabor A. Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 2005; 105: 537-542.
28. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543-550.
29. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14: 368-374.
30. Wells G, Shea B, O'Connell D etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site 2012.
31. Millett GA, Flores SA, Marks G, Reed JB, Herbst JH. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008; 300: 1674-1684.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
33. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
34. Thompson SG, Higgins J. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573.
35. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
37. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 2007; 26: 4544-4562.
38. Nucci LB, Schmidt MI, Duncan BB, Fuchs SC, Fleck ET, Santos Britto MM. Nutritional status of pregnant women: prevalence and associated pregnancy outcomes. Rev Saude Publica 2001; 35: 502-507.
39. Belogolovkin V, Eddleman KA, Malone FD etal. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med 2007; 20: 509-513.
40. Ogunyemi D, Hullett S, Leeper J, Risk A. Prepregnancy body mass index, weight gain during pregnancy, and perinatal outcome in a rural black population. J Matern Fetal Med 1998; 7: 190-193.
41. Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP. Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 2006; 95: 242-247.
42. Gaio DS, Schmidt MI, Duncan BB, Nucci LB, Matos MC, Branchtein L. Hypertensive disorders in pregnancy: frequency and associated factors in a cohort of Brazilian women. Hypertens Pregnancy 2001; 20: 269-281.
43. Ananth CV, Vintzileos AM. Ischemic placental disease: epidemiology and risk factors. Eur J Obstet Gynecol Reprod Biol 2011; 159: 77-82.
44. Persson M, Pasupathy D, Hanson U, Westgren M, Norman M. Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study. BMJ Open 2012; 2: e000601.
45. El-Gilany AH, Hammad S. Body mass index and obstetric outcomes in pregnant in Saudi Arabia: a prospective cohort study. Ann Saudi Med 2010; 30: 376-380.
46. Burstein E, Levy A, Mazor M, Wiznitzer A, Sheiner E. Pregnancy outcome among obese women: a prospective study. Am J Perinatol 2008; 25: 561-566.
47. Hauger MS, Gibbons L, Vik T, Belizan JM. Prepregnancy weight status and the risk of adverse pregnancy outcome. Acta Obstet Gynecol Scand 2008; 87: 953-959.
48. Clausen T, Oyen N, Henriksen T. Pregnancy complications by overweight and residential area. A prospective study of an urban Norwegian cohort. Acta Obstet Gynecol Scand 2006; 85: 526-533.
49. Chu SY, Kim SY, Lau J etal. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197: 223-228.
50. McDonald SD, Han Z, Mulla S, Beyene J. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010; 341: c3428.
51. Chu SY, Callaghan WM, Kim SY etal. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007; 30: 2070-2076.
52. Chu SY, Kim SY, Schmid CH etal. Maternal obesity and risk of cesarean delivery: a meta-analysis. Obes Rev 2007; 8: 385-394.
53. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009; 301: 636-650.
54. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010; 140: 365-371.
55. Greenwood JP, Scott EM, Walker JJ, Stoker JB, Mary DA. The magnitude of sympathetic hyperactivity in pregnancy-induced hypertension and preeclampsia. Am J Hypertens 2003; 16: 194-199.
56. Fischer T, Schobel HP, Frank H, Andreae M, Schneider KT, Heusser K. Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia. Eur J Clin Invest 2004; 34: 443-448.
57. Zavalza-Gomez AB. Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet 2011; 283: 415-422.
58. Thangaratinam S, Rogozinska E, Jolly K etal. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012; 344: e2088.
59. Thangaratinam S, Rogozinska E, Jolly K etal. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technol Assess 2012; 16: iii-iv, 1-191.
60. Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, Maria Siega-Riz A. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 2010; 116: 1191-1195.
61. Stewart L, Parmar M. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993; 341: 418-422.